Status:
COMPLETED
Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening
Lead Sponsor:
Georgetown University
Collaborating Sponsors:
Prevent Cancer Foundation
Conditions:
Smoking
Lung Cancer
Eligibility:
All Genders
55-80 years
Phase:
PHASE3
Brief Summary
In 2011, the National Lung Screening Trial (NLST) reported that lung cancer mortality was reduced by 20% with spiral computed tomography (CT) compared to chest X-ray. It is estimated that 8 million pe...
Detailed Description
Although abstinence from tobacco remains the best method of lung cancer prevention, recent evidence from the National Lung Screening Trial indicated that lung cancer mortality was reduced by 20% with ...
Eligibility Criteria
Inclusion
- 55-80 years old
- current smoker
- \> 30-pack years
- English-speaking
- ability to provide meaningful consent
- enrolled to undergo lung cancer screening. -
Exclusion
- history of lung cancer
- current treatment for other cancer -
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT02267096
Start Date
January 1 2014
End Date
August 1 2016
Last Update
October 19 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgetown University Medical Center
Washington D.C., District of Columbia, United States, 20007
2
Lahey Hospital and Medical Center
Burlington, Massachusetts, United States, 01805
3
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601